Montelukast%25252525252525252525252525252520levocetrizine

# Montelukast-Levocetirizine ## Overview This is a combination of a leukotriene receptor antagonist (montelukast) and a third-generation, non-sedating histamine H1-receptor antagonist (levocetirizine). They are frequently prescribed together off-label for the management of allergic rhinitis or chronic urticaria, though fixed-dose combination products vary by region. ## Primary Indications - Allergic Rhinitis (Seasonal or Perennial) - Chronic Idiopathic Urticaria (CIU) ## Adult Dosing - **Montelukast:** 10 mg orally once daily in the evening. - **Levocetirizine:** 5 mg orally once daily in the evening. ## Pediatric Dosing - **Children 6–14 years:** - Montelukast: 5 mg (chewable) once daily in the evening. - Levocetirizine: 2.5 mg once daily in the evening. - **Children 6 months–5 years:** - Montelukast: 4 mg (granules or chewable) once daily in the evening. - Levocetirizine: 1.25 mg (oral solution) once daily in the evening. *Note: Dosages for children under 6 years are highly weight and age-dependent; verify current pediatric dosing references.* ## Dose Adjustments - **Renal Impairment:** Levocetirizine requires adjustment. In patients with CrCl 30–49 mL/min, use 2.5 mg every 48 hours; in CrCl 10–29 mL/min, use 2.5 mg twice weekly. No adjustment is typically required for montelukast. - **Hepatic Impairment:** No adjustment required for levocetirizine. Use caution with montelukast in mild-to-moderate impairment; no specific dosing guidelines exist for severe impairment. ## Contraindications - Known hypersensitivity to montelukast, levocetirizine, cetirizine, or hydroxyzine. - Severe renal impairment (CrCl <10 mL/min) or hemodialysis (levocetirizine). ## Adverse Effects - **Montelukast:** Headache, upper respiratory infection, diarrhea. **Black Box Warning/Alert:** Serious neuropsychiatric events (agitation, depression, sleep disturbances, suicidal ideation). - **Levocetirizine:** Somnolence (less than first-gen antihistamines, but significant in some patients), nasopharyngitis, fatigue, dry mouth. ## Key Drug Interactions - **CNS Depressants:** Levocetirizine may exhibit additive sedative effects; use caution with alcohol, benzodiazepines, or opioids. - **CYP2C8/2C9 Inducers (e.g., Rifampin):** May decrease montelukast concentrations. - **P-glycoprotein inhibitors:** May increase exposure to levocetirizine. ## Monitoring - Monitor for changes in mood, behavior, or sleep patterns (montelukast). - Assess for daytime somnolence and performance impairment (levocetirizine). - Monitor for reduction of allergic symptoms or urticaria control. ## Clinical Pearls - **Administration:** Montelukast is commonly taken in the evening to optimize control of nocturnal symptoms. Levocetirizine should be taken in the evening to minimize the impact of sedation during the day. - **Neuropsychiatric Risk:** Counsel patients/caregivers to discontinue montelukast and contact a provider immediately if significant behavioral or mood changes occur. - **Combination availability:** Ensure the prescription specifies individual ingredients if a fixed-dose combination product is not available or appropriate for the patient's specific age group. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical protocols and safety guidelines change frequently. Always verify the most current prescribing information, dose-weight calculations for pediatric patients, and renal adjustments through official resources (e.g., package inserts, Lexicomp, or UpToDate) before prescribing or administering medication.